We are UTR Therapeutics Inc. a pre-clinical NYC based biotech born from the Nucleate Activator Program. Our technology is a breakthrough discovery which can overwrite any endogenous transcript. The technology can uniquely target and degrade any transcript of interest which we have proven in multiple difficult to treat cancers. Learn more by visiting us at www.utrtherapeutics.com or contacting us at chidi@utrtherapeutics.com

Notable Recognitions
2022: 
Nucleate Genentech Award
Illumina Accelerator Sequencing Grant
2023:
Deerfield Management and Economic Development Committee of NY xSeed Award
40 under 40 in Cancer [Chidiebere Awah], Association of Value Based Cancer Care (AVBCC)
July 31 2023- Pre-IND Feedback from FDA for UTRxM1-18

UTR Therapeutics Inc.

Org chart

Teams

Offices

UTR Therapeutics Inc.

Org chart

Teams

Offices

Related companies